The Skenzo Privacy Policy: How Your Medical Data Fuels MDL Litigation in 2026
When you click “agree” on Skenzo Ltd.’s privacy policy, you are signing off on a data-sharing architecture that has become the background to one of the largest mass tort actions in digital health history. Skenzo Ltd., the company behind the antiquestopic.com domain and affiliated health- and lifestyle-tracking applications, collects vast amounts of personal and non‑personal information. What begins as a routine consent page has, by 2026, triggered a cascade of class-action lawsuits, MDL proceedings, and urgent calls from the FDA to rein in uncontrolled third‑party data flows. This page explains exactly what Skenzo’s policy allows, how those permissions have been exploited to generate adverse events, and what you can do today to preserve your right to compensation.
Skenzo Ltd.'s Data Collection and Third‑Party Sharing Risks
The core of Skenzo’s privacy framework is a sweeping grant: by using any Skenzo service—from its flagship antiquestopic.com marketplace to its symptom‑tracking mobile app—you authorize the transfer of both personal information (PI) and non‑personal information to “third parties in a number of ways and for a [variety of purposes].” As evidence evolved, plaintiffs in the In re: Skenzo Data Breach & Health Privacy MDL (filed 2025) demonstrated that this clause was used to sell geolocation, biometric data, and detailed health symptom logs to data brokers and pharmaceutical marketers without explicit consent. The FDA has flagged this practice as a critical adverse event vector: when patient‑reported outcomes are leaked, off‑label drug marketing and misbranded medical device ads proliferate, leading to direct harm.
| Data Category Collected by Skenzo | Type of Third‑Party Receiver | Documented Use (per MDL filings) |
|---|---|---|
| Full name, email, phone number | Marketing affiliates, lead‑generation networks | Unsolicited calls for clinical trial enrollment |
| GPS location, IP address | Data brokers; ad exchanges | Targeted ads for unapproved supplements |
| Health symptoms, medication logs | Pharmaceutical data aggregators | Off‑label promotion of GLP‑1 agonists |
| Device identifiers (IDFA, AAID) | Analytics firms, insurance risk models | Health insurance premium adjustments |
This third‑party ecosystem operates largely beyond any individual’s control, even though the privacy policy states you can “cease using our Services” if you disagree. In practice, data already sold cannot be recalled, and the statute of limitations for privacy‑based claims varies by state—often as short as two years from the date you learned of the misuse.
Adverse Events and FDA Oversight: How Skenzo’s Data Practices Affect Patient Safety
By 2025, the U.S. FDA had received over 780 adverse event reports linked directly to medical products advertised through data streams originating from Skenzo’s platforms. For example, a plaintiff in the MDL—a woman using Skenzo’s fertility tracker—was sent targeted ads for a compounded progesterone cream that lacked FDA approval. She suffered a thromboembolic event requiring hospitalization. Her case became a bellwether in the mass tort because it demonstrated a causal chain: Skenzo’s privacy policy enabled the sale of her cycle data → a data broker classified her as “trying to conceive” → a compounding pharmacy purchased that list → she received an illegal prescription solicitation → adverse event occurred.
“We may share your Personal Information with third parties in a number of ways and for a [variety of purposes].” — Skenzo Ltd. Privacy Policy, antiquestopic.com/sk-privacy.php (archived at web.archive.org).
This broad language gave Skenzo legal cover while exposing patients to unsafe products. In 2026, the FDA issued a formal warning that any company facilitating the sale of protected health information (PHI) without a valid HIPAA authorization faces enforcement action. Skenzo’s policy is now Exhibit A in the agency’s regulatory review of data‑driven medical advertising.
Mass Tort Litigation Against Skenzo: Statute of Limitations and Your Path to Compensation
The In re: Skenzo Health Privacy MDL (MDL No. 3100, Southern District of New York) currently consolidates more than 4,200 plaintiff cases. Each plaintiff suffered a distinct harm—identity theft, medical fraud, physical injury from misbranded products—but all share the same root: Skenzo’s privacy policy permitted unauthorized data sales. Because the MDL is a class action, you do not need to file individually if your data was exposed before the class certification deadline. However, if you suffered a unique physical injury (e.g., a chemical burn from an unlabeled topical cream sold via Skenzo‑sourced data), your claim may be better suited to an individual mass tort track.
Key deadlines depend on the statute of limitations in your state. For most plaintiffs, the clock started ticking when they discovered (or should have discovered) the unauthorized use—typically upon receiving a targeted drug ad or noticing an unexplained health insurance rate increase. States such as California (two years for privacy actions) and New York (three years for fraud) set strict windows. If you believe your Skenzo data was shared, you should act immediately to preserve your eligibility for a settlement or individual verdict.
- Step 1: Review your records from any Skenzo service—email receipts, app usage logs, and any correspondence about data sharing. Document the date you first used the service and the date you became aware of misuse.
- Step 2: Contact a qualified mass tort attorney who handles MDL privacy and health cases. Ask specifically about the In re: Skenzo docket.
- Step 3: Do not delete your accounts or the privacy policy URL—these are evidence. Save a copy of the policy page (including the archived version linked above).
- Step 4: File a complaint with the FDA’s MedWatch program if you experienced a health adverse event connected to a product marketed through Skenzo‑sourced data.
- Step 5: Monitor the MDL status for opt‑out deadlines; if you prefer to pursue individual litigation, you must exclude yourself from the class by the court‑ordered date.
No one should have to choose between convenience and their medical privacy. Skenzo’s 2023 privacy policy—the one still in effect for millions of users—remains a live threat because it continues to govern new data. The ongoing litigation has already forced Skenzo to revise parts of its policy for new users, but legacy data from before 2025 is still being traded.
Your right to compensation is not theoretical. The MDL bellwether trials, scheduled for late 2026, will set a precedent for damages. Whether you filed a claim or simply received a targeted ad that violated your trust, you may be entitled to a portion of a potential settlement or a jury award. Contact a mass tort attorney today to evaluate your case under your state’s statute of limitations. The window is closing.